Vast Therapeutics
  • Home
  • About
    • Company Overview
    • Our Team
    • Scientific Advisory Board
    • Careers
  • Technology
    • Nitric Oxide
    • Need for Antibiotic Alternatives
    • Broad Spectrum Efficacy
  • Applications
    • Cystic Fibrosis
    • NTM Lung Disease
    • Other Targets
  • Media
  • Investors

Media

Chuck Swoboda named Vast Therapeutics President & CEO

1/15/2021

 
​Vast Therapeutics, Inc announced that Chuck Swoboda has joined the company as President & CEO.  Prior to joining the company, he spent more than 25 years at Cree, Inc, where he helped lead the company from $6 million in revenue to over $1.6 billion.  During his 16 years as Cree CEO, the company was recognized as one of MIT Technology Review's 50 Smartest Companies and as one of Fast Company's World's 50 Most Innovative Companies.
About Vast Therapeutics, Inc.
Vast Therapeutics, a subsidiary of KNOW Bio, LLC​, a preclinical stage biotechnology company, focused on harnessing nitric oxide's unique properties to treat drug-resistant microbial infections. Vast Therapeutics' patented technology is being used to create a new class of antibiotic alternative compounds that deliver broad-spectrum antimicrobial activity without the risk of developing drug resistance common to traditional antibiotics. More info available at ​www.vasttherapeutics.com.


    Archives

    January 2021
    September 2020
    October 2019
    May 2019
    January 2019
    December 2018
    May 2018
    February 2018
    January 2018
    November 2017
    October 2017
    July 2017
    April 2017
    January 2017


    ​Categories

    All
    Anthrax
    BIOC11
    BIOC51
    Biotech Showcase
    CED
    CFF
    Conference
    COVID-19
    Cystic Fibrosis
    Funding
    GAIN Act
    NACFC
    NCBIO
    News Article
    Nitric Oxide
    NTM Animal Model
    Partnership
    Patent
    Pathogens
    Press Release
    QIDP Status
    SARS-CoV-2
    Superbugs
    Therapy
    Video

    RSS Feed

Vast Therapeutics logo - white

Address

​4222 Emperor Blvd. Suite 470
​Durham, NC 27703

Contact Us

info@vasttherapeutics.com

Sector

Biopharmaceutical

Industry

​Biotechnology

    Sign Up for Email Alerts

Submit
​Forward-Looking Statement | Privacy | Terms of Use | Site Map
​Copyright © 2021 Vast Therapeutics - All Rights Reserved
Picture
  • Home
  • About
    • Company Overview
    • Our Team
    • Scientific Advisory Board
    • Careers
  • Technology
    • Nitric Oxide
    • Need for Antibiotic Alternatives
    • Broad Spectrum Efficacy
  • Applications
    • Cystic Fibrosis
    • NTM Lung Disease
    • Other Targets
  • Media
  • Investors